PMID- 11158314 OWN - NLM STAT- MEDLINE DCOM- 20010322 LR - 20181113 IS - 0270-7306 (Print) IS - 1098-5549 (Electronic) IS - 0270-7306 (Linking) VI - 21 IP - 4 DP - 2001 Feb TI - The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. PG - 1285-96 AB - Alternative splicing of cardiac troponin T (cTNT) exon 5 undergoes a developmentally regulated switch such that exon inclusion predominates in embryonic, but not adult, striated muscle. We previously described four muscle-specific splicing enhancers (MSEs) within introns flanking exon 5 in chicken cTNT that are both necessary and sufficient for exon inclusion in embryonic muscle. We also demonstrated that CUG-binding protein (CUG-BP) binds a conserved CUG motif within a human cTNT MSE and positively regulates MSE-dependent exon inclusion. Here we report that CUG-BP is one of a novel family of developmentally regulated RNA binding proteins that includes embryonically lethal abnormal vision-type RNA binding protein 3 (ETR-3). This family, which we call CELF proteins for CUG-BP- and ETR-3-like factors, specifically bound MSE-containing RNAs in vitro and activated MSE-dependent exon inclusion of cTNT minigenes in vivo. The expression of two CELF proteins is highly restricted to brain. CUG-BP, ETR-3, and CELF4 are more broadly expressed, and expression is developmentally regulated in striated muscle and brain. Changes in the level of expression and isoforms of ETR-3 in two different developmental systems correlated with regulated changes in cTNT splicing. A switch from cTNT exon skipping to inclusion tightly correlated with induction of ETR-3 protein expression during differentiation of C2C12 myoblasts. During heart development, the switch in cTNT splicing correlated with a transition in ETR-3 protein isoforms. We propose that ETR-3 is a major regulator of cTNT alternative splicing and that the CELF family plays an important regulatory role in cell-specific alternative splicing during normal development and disease. FAU - Ladd, A N AU - Ladd AN AD - Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA. FAU - Charlet, N AU - Charlet N FAU - Cooper, T A AU - Cooper TA LA - eng SI - GENBANK/AF329264 SI - GENBANK/AF329265 SI - GENBANK/AF329266 GR - R01 AR045653/AR/NIAMS NIH HHS/United States GR - AR45653/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Mol Cell Biol JT - Molecular and cellular biology JID - 8109087 RN - 0 (CELF Proteins) RN - 0 (CELF1 Protein) RN - 0 (CELF1 protein, human) RN - 0 (CELF2 protein, human) RN - 0 (CELF3 protein, human) RN - 0 (CELF4 protein, human) RN - 0 (CELF5 protein, human) RN - 0 (DNA Primers) RN - 0 (Nerve Tissue Proteins) RN - 0 (RNA-Binding Proteins) RN - 0 (Ribonucleoproteins) RN - 0 (Troponin T) SB - IM MH - Adult MH - *Alternative Splicing MH - Amino Acid Sequence MH - Animals MH - Base Sequence MH - Brain/growth & development/metabolism MH - CELF Proteins MH - CELF1 Protein MH - Cell Line MH - Chickens MH - DNA Primers/genetics MH - Enhancer Elements, Genetic MH - Exons MH - Female MH - Gene Expression MH - Humans MH - Male MH - Molecular Sequence Data MH - Muscle Development MH - Muscle, Skeletal/growth & development/metabolism MH - Nerve Tissue Proteins MH - RNA-Binding Proteins/*genetics/*metabolism MH - Ribonucleoproteins/genetics MH - Sequence Homology, Amino Acid MH - Tissue Distribution MH - Troponin T/genetics PMC - PMC99581 EDAT- 2001/02/07 11:00 MHDA- 2001/03/27 10:01 PMCR- 2001/02/01 CRDT- 2001/02/07 11:00 PHST- 2001/02/07 11:00 [pubmed] PHST- 2001/03/27 10:01 [medline] PHST- 2001/02/07 11:00 [entrez] PHST- 2001/02/01 00:00 [pmc-release] AID - 1566 [pii] AID - 10.1128/MCB.21.4.1285-1296.2001 [doi] PST - ppublish SO - Mol Cell Biol. 2001 Feb;21(4):1285-96. doi: 10.1128/MCB.21.4.1285-1296.2001.